APELLIS PHARMACEUTICALS, INC. (APLS) — Analysis Summary
APELLIS PHARMACEUTICALS, INC. (APLS) has a market cap of $0.00M with year-over-year revenue growth of +28.5%. Net margin stands at 2.2%. The stock trades at a P/E ratio of 0.0.
Key Takeaways
- Revenue changed +28.5% year-over-year
- Net margin of 2.2%
- P/E ratio of 0.0
Compared with its sector, APLS posted revenue growth of +28.5% and trades at a P/E of 0.0.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.